April 2021

21 Apr Kromatid Receives $2M Investment From BroadOak Capital Partners

Posted at 00:00h in Investment News, News by BroadOak 0 Comments

BroadOak Capital Partners invested growth capital in KromaTiD. KromaTiD sells structural genomic products and tech-enabled services to optimize gene editing for research and clinical purposes. The funding will help accelerate the commercialization of its recently launched direction genomic hybridization In-Site and SCREEN products for gene...

21 Apr KCAS Sells To Vitruvian

Posted at 00:00h in Advisory News, News by BroadOak 0 Comments

BroadOak Capital Partners advised KCAS Bioanalytical and Biomarker Services (“KCAS”) on the sale of the company to Vitruvian. KCAS is a leading contract research organization providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and animal health industries. The full press release...

Stay connected

Partner with BroadOak

Investing

Advisory

About

Portfolio

Transactions

News

Contact

Team

Investor Login

Join our newsletter.

Member FINRA | SIPC
Business Continuity Disclosure
Privacy Policy